Clinical Trial Detail

NCT ID NCT02531308
Title Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rush University Medical Center
Indications

diffuse large B-cell lymphoma

Therapies

Metformin

Cyclophosphamide + Doxorubicin + Prednisone + Vincristine Sulfate

Pegfilgrastim

Rituximab

Age Groups: adult

No variant requirements are available.